428 related articles for article (PubMed ID: 21784838)
1. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.
Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838
[TBL] [Abstract][Full Text] [Related]
2. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.
Ghane Sharbaf F; Assadi F
Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.
Kanbay M; Ozkara A; Selcoki Y; Isik B; Turgut F; Bavbek N; Uz E; Akcay A; Yigitoglu R; Covic A
Int Urol Nephrol; 2007; 39(4):1227-33. PubMed ID: 17701281
[TBL] [Abstract][Full Text] [Related]
4. Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia.
Takir M; Kostek O; Ozkok A; Elcioglu OC; Bakan A; Erek A; Mutlu HH; Telci O; Semerci A; Odabas AR; Afsar B; Smits G; ALanaspa M; Sharma S; Johnson RJ; Kanbay M
J Investig Med; 2015 Dec; 63(8):924-9. PubMed ID: 26571421
[TBL] [Abstract][Full Text] [Related]
5. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.
Goicoechea M; de Vinuesa SG; Verdalles U; Ruiz-Caro C; Ampuero J; Rincón A; Arroyo D; Luño J
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1388-93. PubMed ID: 20538833
[TBL] [Abstract][Full Text] [Related]
6. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
[TBL] [Abstract][Full Text] [Related]
7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
8. The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol.
Saito J; Matsuzawa Y; Ito H; Omura M; Ito Y; Yoshimura K; Yajima Y; Kino T; Nishikawa T
Endocr Res; 2010; 35(4):145-54. PubMed ID: 20958145
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Allopurinol on Renal Function.
Krishnamurthy A; Lazaro D; Stefanov DG; Blumenthal D; Gerber D; Patel S
J Clin Rheumatol; 2017 Jan; 23(1):1-5. PubMed ID: 28002149
[TBL] [Abstract][Full Text] [Related]
10. The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients.
Bayram D; Tuğrul Sezer M; İnal S; Altuntaş A; Kıdır V; Orhan H
Clin Exp Nephrol; 2015 Jun; 19(3):443-9. PubMed ID: 25082656
[TBL] [Abstract][Full Text] [Related]
11. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease.
Yelken B; Caliskan Y; Gorgulu N; Altun I; Yilmaz A; Yazici H; Oflaz H; Yildiz A
Clin Nephrol; 2012 Apr; 77(4):275-82. PubMed ID: 22445470
[TBL] [Abstract][Full Text] [Related]
12. Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia.
Meléndez-Ramírez G; Pérez-Méndez O; López-Osorio C; Kuri-Alfaro J; Espinola-Zavaleta N
Endocr Res; 2012; 37(1):1-6. PubMed ID: 21977925
[TBL] [Abstract][Full Text] [Related]
13. Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease.
Lee JW; Lee KH
Int Urol Nephrol; 2019 Mar; 51(3):467-473. PubMed ID: 30604229
[TBL] [Abstract][Full Text] [Related]
14. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
[TBL] [Abstract][Full Text] [Related]
15. Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease.
Satirapoj B; Wirajit O; Burata A; Supasyndh O; Ruangkanchanasetr P
J Med Assoc Thai; 2015 Dec; 98(12):1155-61. PubMed ID: 27004299
[TBL] [Abstract][Full Text] [Related]
16. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
[TBL] [Abstract][Full Text] [Related]
17. Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Liu C; Zhao Q; Zhen Y; Gao Y; Tian L; Wang L; Ji L; Liu G; Ji Z; Liu K
Can J Cardiol; 2013 Sep; 29(9):1048-54. PubMed ID: 23395281
[TBL] [Abstract][Full Text] [Related]
18. Allopurinol Against Progression of Chronic Kidney Disease.
Golmohammadi S; Almasi A; Manouchehri M; Omrani HR; Zandkarimi MR
Iran J Kidney Dis; 2017 Jul; 11(4):286-293. PubMed ID: 28794291
[TBL] [Abstract][Full Text] [Related]
19. The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.
Liu X; Wang H; Ma R; Shao L; Zhang W; Jiang W; Luo C; Zhai T; Xu Y
Clin Exp Nephrol; 2019 Mar; 23(3):362-370. PubMed ID: 30291473
[TBL] [Abstract][Full Text] [Related]
20. The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.
Saddekni MB; Saag KG; Dudenbostel T; Oparil S; Calhoun DA; Sattui SE; Feig DI; Muntner P; Redden DT; Foster PJ; Rahn EJ; Biggers SR; Li P; Gaffo AL
Contemp Clin Trials; 2016 Sep; 50():238-44. PubMed ID: 27587282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
